Back
Grace Therapeutics Stock Predictions
Should You Invest in this AI Marketing High-Growth Startup by April?
Invest Now & Secure Your Stake in RAD Intel
Sell
27
GRCE
Grace Therapeutics
Last Price:
$2.24
Seasonality Move:
-1.38%
7 Day Trial
ALL ACCESS PASS
$
7
Missed Airbnb? Your Next Chance Could Be Sitting In Your Pocket
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Grace Therapeutics Stock Forecast
-
Is Grace Therapeutics Stock Undervalued?The current Grace Therapeutics [GRCE] share price is $2.29. The Score for GRCE is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
-
GRCE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Grace Therapeutics Stock Go Up Next Year?
Data Unavailable
Grace Therapeutics Stock Rating
Data Unavailable
Grace Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
acastipharma.com
52-Week Data
52-Week High:
4.97
52-Week Low:
2.13
Prediction Charts
Market Cap:
31.4M
Price in USD:
2.29
Volume:
18.5K
Beta:
1.19
Technical Analysis
SMA50:
3.39
SMA100:
3.42
SMA200:
3.11
52-Wk Change:
-32.65%
Stock Predictions
-
Is Grace Therapeutics stock public?Yes, Grace Therapeutics is a publicly traded company.
-
What is the Grace Therapeutics stock quote today?The Grace Therapeutics stock price is 2.29 USD today.
-
How to buy Grace Therapeutics stock online?You can buy Grace Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Feb-20 | 3.38 | 3.39 | 3.43 | 3.32 |
| Feb-21 | 3.39 | 3.29 | 3.39 | 3.23 |
| Feb-25 | 3.05 | 2.84 | 3.08 | 2.82 |
| Feb-26 | 2.84 | 3.07 | 3.20 | 2.80 |
| Feb-27 | 3.04 | 3.02 | 3.17 | 2.97 |
| Feb-28 | 2.93 | 2.96 | 3.10 | 2.89 |
| Mar-3 | 2.97 | 2.65 | 2.97 | 2.62 |
| Mar-4 | 2.61 | 2.75 | 2.80 | 2.45 |
| Mar-5 | 2.75 | 2.84 | 2.85 | 2.70 |
| Mar-6 | 2.77 | 2.70 | 2.84 | 2.66 |
| Mar-7 | 2.67 | 2.54 | 2.67 | 2.40 |
| Mar-11 | 2.41 | 2.35 | 2.47 | 2.26 |
| Mar-12 | 2.36 | 2.30 | 2.44 | 2.28 |
| Mar-13 | 2.29 | 2.29 | 2.52 | 2.25 |
Grace Therapeutics Earnings
Data Unavailable
Grace Therapeutics Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.07 per share, an increase this year of $0.20 per share, and an increase next year of $0.40 per share.
* Grace Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.